PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1629123
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1629123
U.S. Endoscope Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2030)
The U.S. endoscope market is projected to grow from $9,830.2 million in 2024 to $14,925.6 million by 2030, registering a compound annual growth rate (CAGR) of 7.2%. This growth is fueled by the rising prevalence of gastrointestinal disorders, the aging population, and increasing healthcare expenditures. Additionally, the growing demand for minimally invasive surgical procedures and continuous advancements in endoscopic technologies are further driving market expansion. Hospitals and ambulatory surgery centers remain key end-users, leveraging endoscopic devices to improve diagnostic accuracy and therapeutic outcomes.
Key Insights
Increasing adoption of minimally invasive procedures is driving the demand for endoscopic devices due to reduced patient trauma, faster recovery times, and lower healthcare costs.
Technological advancements, such as enhanced imaging systems and flexible designs, are improving the precision and efficiency of endoscopic procedures.
The aging population is contributing to a higher prevalence of gastrointestinal and age-related disorders, fueling the need for endoscopic diagnostics and treatments.
Hospitals represent the largest end-user segment, extensively utilizing endoscopic devices across diagnostic and therapeutic applications.
Ambulatory surgery centers are witnessing growing adoption of endoscopic equipment, improving accessibility for outpatient procedures.
Rising healthcare expenditures in the U.S. are promoting investments in advanced medical technologies, including innovative endoscopic devices.
The market is experiencing strong regulatory support, with FDA approvals for new and advanced endoscopic products enabling their adoption in clinical practices.
Chronic diseases, including colorectal cancer and Crohn's disease, are significantly increasing the demand for endoscopic diagnostics and treatments.
The competitive landscape is characterized by ongoing innovation, with companies focusing on the development of advanced endoscopic devices to meet evolving clinical demands.
Challenges such as cost concerns and regulatory complexities remain, but advancements in technology and increasing healthcare awareness continue to drive growth.
Table of Contents
Chapter 1. Research Background
- 1.1 Research Objectives
- 1.2 Market Definition
- 1.3 Analysis Period
- 1.4 Market Data Reporting Unit
- 1.4.1 Value
- 1.5 Market Size Breakdown by Segment
- 1.5.1 Market Segmentation by Type
- 1.5.2 Market Segmentation by End User
- 1.5.3 Market Segmentation by State
- 1.6 Key Stakeholders
Chapter 2. Research Methodology
- 2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
- 2.1.3 P&S Intelligence Database
- 2.2 Primary Research
- 2.2.1 Breakdown of Primary Research, by Industry Participant
- 2.2.2 Breakdown of Primary Research, by Designation
- 2.2.3 Breakdown of Primary Research, by Company Type
- 2.3 Market Size Estimation
- 2.4 Data Triangulation
- 2.5 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
- 4.1 Prevalence of Chronic Diseases
- 4.2 Emergency Department Visits
- 4.3 Number of Endoscopists
- 4.4 Number of Hospitals State-Wise
- 4.5 Number of Endoscopy Centers in U.S. States
Chapter 5. Industry Outlook
- 5.1 Market Dynamics
- 5.1.1 Trends
- 5.1.1.1 Increasing number of product launches
- 5.1.1.2 Growing number of partnerships and collaborations
- 5.1.1.3 Inclination toward mergers and acquisitions
- 5.1.2 Drivers
- 5.1.2.1 Growing prevalence of GI disorders
- 5.1.2.2 Increasing healthcare expenditure
- 5.1.2.3 Technological advancements
- 5.1.2.4 Growing geriatric population in the country
- 5.1.2.5 Increasing Investments for launching and expanding product lines
- 5.1.2.6 Shift toward minimally invasive procedures
- 5.1.3 Impact Analysis of Drivers on Market Forecast
- 5.1.4 Restraints
- 5.1.4.1 High costs
- 5.1.4.2 Stringent regulatory requirements
- 5.1.5 Impact Analysis of Restraints on Market Forecast
- 5.1.1 Trends
- 5.2 Impact of COVID-19
- 5.3 Porter's Five Forces Analysis
- 5.3.1 Bargaining Power of Buyers
- 5.3.2 Bargaining Power of Suppliers
- 5.3.3 Intensity of Rivalry
- 5.3.4 Threat of New Entrants
- 5.3.5 Threat of Substitutes
Chapter 6. U.S. Market Size and Forecast
- 6.1 Overview
- 6.2 Market Revenue, by Type (2017-2030)
- 6.2.1 Flexible Endoscopes Market Revenue, by Type (2017-2030)
- 6.2.2 Rigid Endoscopes Market Revenue, by Type (2017-2030)
- 6.3 Market Revenue, by End User (2017-2030)
- 6.4 Market Revenue, by State (2017-2030)
Chapter 7. Competitive Landscape
- 7.1 List of Major Market Players and Their Offerings
- 7.2 Strategic Developments of Key Players
- 7.2.1 Product Launches and Approvals
- 7.2.2 Mergers and Acquisitions
- 7.2.3 Partnerships and Collaborations
- 7.2.4 Other Developments
Chapter 8. Company Profiles
- 8.1 Smith & Nephew Inc.
- 8.1.1 Business Overview
- 8.1.2 Product and Service Offerings
- 8.1.3 Key Financial Summary
- 8.2 The Cooper Companies Inc.
- 8.2.1 Business Overview
- 8.2.2 Product and Service Offerings
- 8.2.3 Key Financial Summary
- 8.3 Intuitive Surgical Inc.
- 8.3.1 Business Overview
- 8.3.2 Product and Service Offerings
- 8.3.3 Key Financial Summary
- 8.4 Richard Wolf Medical Instruments Corporation
- 8.4.1 Business Overview
- 8.4.2 Product and Service Offerings
- 8.5 FUJIFILM Holdings America Corporation
- 8.5.1 Business Overview
- 8.5.2 Product and Service Offerings
- 8.5.3 Key Financial Summary
- 8.6 PENTAX Medical
- 8.6.1 Business Overview
- 8.6.2 Product and Service Offerings
- 8.7 KARL STORZ SE & Co. KG
- 8.7.1 Business Overview
- 8.7.2 Product and Service Offerings
- 8.8 CONMED Corporation
- 8.8.1 Business Overview
- 8.8.2 Product and Service Offerings
- 8.8.3 Key Financial Summary
- 8.9 Arthrex Inc.
- 8.9.1 Business Overview
- 8.9.2 Product and Service Offerings
- 8.10 Olympus Corporation of the Americas
- 8.10.1 Business Overview
- 8.10.2 Product and Service Offerings
- 8.10.3 Key Financial Summary
- 8.11 Henke Sass Wolf of America Inc.
- 8.11.1 Business Overview
- 8.11.2 Product and Service Offerings
- 8.12 AMBU INC.
- 8.12.1 Business Overview
- 8.12.2 Product and Service Offerings
- 8.12.3 Key Financial Summary
- 8.13 Boston Scientific Corporation
- 8.13.1 Business Overview
- 8.13.2 Product and Service Offerings
- 8.13.3 Key Financial Summary
- 8.14 Medtronic plc
- 8.14.1 Business Overview
- 8.14.2 Product and Service Offerings
- 8.14.3 Key Financial Summary
- 8.15 Stryker Corporation
- 8.15.1 Business Overview
- 8.15.2 Product and Service Offerings
- 8.15.3 Key Financial Summary
- 8.16 Cook Medical LLC
- 8.16.1 Business Overview
- 8.16.2 Product and Service Offerings
- 8.17 STERIS
- 8.17.1 Business Overview
- 8.17.2 Product and Service Offerings
- 8.17.3 Key Financial Summary
- 8.18 B. Braun SE
- 8.18.1 Business Overview
- 8.18.2 Product and Service Offerings
- 8.18.3 Key Financial Summary
- 8.19 Ethicon Endo-Surgery, Inc.
- 8.19.1 Business Overview
- 8.19.2 Product and Service Offerings
Chapter 9. Appendix
- 9.1 Sources and References
- 9.2 Related Reports
LIST OF TABLES
- TABLE 1 ANALYSIS PERIOD OF THE STUDY
- TABLE 2 EMERGENCY DEPARTMENT VISITS IN THE U.S., BY REGION (2021)
- TABLE 3 NUMBER OF ENDOSCOPISTS IN THE U.S., BY STATE (2024)
- TABLE 4 NUMBER OF HOSPITALS IN THE U.S., BY STATE (2022)
- TABLE 5 NUMBER OF ENDOSCOPY CENTERS STATE-WISE (2022)
- TABLE 6 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
- TABLE 7 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
- TABLE 8 U.S. ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2017-2024)
- TABLE 9 U.S. ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2025-2030)
- TABLE 10 U.S. FLEXIBLE ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2017-2024)
- TABLE 11 U.S. FLEXIBLE ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2025-2030)
- TABLE 12 U.S. RIGID ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2017-2024)
- TABLE 13 U.S. RIGID ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2025-2030)
- TABLE 14 U.S. ENDOSCOPES MARKET REVENUE, BY END USER, $M (2017-2024)
- TABLE 15 U.S. ENDOSCOPES MARKET REVENUE, BY END USER, $M (2025-2030)
- TABLE 16 U.S. ENDOSCOPES MARKET REVENUE, BY STATE, $M (2017-2024)
- TABLE 17 U.S. ENDOSCOPES MARKET REVENUE, BY STATE, $M (2025-2030)
- TABLE 18 LIST OF MAJOR MARKET PLAYERS AND THEIR OFFERINGS
- TABLE 19 SMITH & NEPHEW INC. - AT A GLANCE
- TABLE 20 SMITH & NEPHEW INC. - KEY FINANCIAL SUMMARY
- TABLE 21 THE COOPER COMPANIES INC. - AT A GLANCE
- TABLE 22 THE COOPER COMPANIES INC. - KEY FINANCIAL SUMMARY
- TABLE 23 INTUITIVE SURGICAL INC. - AT A GLANCE
- TABLE 24 INTUITIVE SURGICAL INC. - KEY FINANCIAL SUMMARY
- TABLE 25 RICHARD WOLF MEDICAL INSTRUMENTS CORPORATION - AT A GLANCE
- TABLE 26 FUJIFILM HOLDINGS AMERICA CORPORATION - AT A GLANCE
- TABLE 27 FUJIFILM HOLDINGS CORPORATION - KEY FINANCIAL SUMMARY
- TABLE 28 PENTAX MEDICAL - AT A GLANCE
- TABLE 29 KARL STORZ SE & CO. KG - AT A GLANCE
- TABLE 30 CONMED CORPORATION - AT A GLANCE
- TABLE 31 CONMED CORPORATION - KEY FINANCIAL SUMMARY
- TABLE 32 ARTHREX INC. - AT A GLANCE
- TABLE 33 OLYMPUS CORPORATION OF THE AMERICAS - AT A GLANCE
- TABLE 34 OLYMPUS CORPORATION OF THE AMERICAS - KEY FINANCIAL SUMMARY
- TABLE 35 HENKE SASS WOLF OF AMERICA INC. - AT A GLANCE
- TABLE 36 AMBU INC. - AT A GLANCE
- TABLE 37 AMBU A/S - KEY FINANCIAL SUMMARY
- TABLE 38 BOSTON SCIENTIFIC CORPORATION - AT A GLANCE
- TABLE 39 BOSTON SCIENTIFIC CORPORATION - KEY FINANCIAL SUMMARY
- TABLE 40 MEDTRONIC PLC - AT A GLANCE
- TABLE 41 MEDTRONIC PLC - KEY FINANCIAL SUMMARY
- TABLE 42 STRYKER CORPORATION - AT A GLANCE
- TABLE 43 STRYKER CORPORATION - KEY FINANCIAL SUMMARY
- TABLE 44 COOK MEDICAL LLC - AT A GLANCE
- TABLE 45 STERIS - AT A GLANCE
- TABLE 46 STERIS - KEY FINANCIAL SUMMARY
- TABLE 47 B. BRAUN SE - AT A GLANCE
- TABLE 48 B. BRAUN SE - KEY FINANCIAL SUMMARY
- TABLE 49 ETHICON ENDO-SURGERY, INC. - AT A GLANCE
LIST OF FIGURES
- FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
- FIG 2 RESEARCH METHODOLOGY
- FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
- FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
- FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
- FIG 6 DATA TRIANGULATION APPROACH
- FIG 7 U.S. ENDOSCOPES MARKET SUMMARY
- FIG 8 BARGAINING POWER OF BUYERS
- FIG 9 BARGAINING POWER OF SUPPLIERS
- FIG 10 INTENSITY OF RIVALRY
- FIG 11 THREAT OF NEW ENTRANTS
- FIG 12 THREAT OF SUBSTITUTES
- FIG 13 U.S. ENDOSCOPES MARKET SNAPSHOT
- FIG 14 U.S. ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2017-2030)
- FIG 15 U.S. FLEXIBLE ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2017-2030)
- FIG 16 U.S. RIGID ENDOSCOPES MARKET REVENUE, BY TYPE, $M (2017-2030)
- FIG 17 U.S. ENDOSCOPES MARKET REVENUE, BY END USER, $M (2017-2030)
- FIG 18 U.S. ENDOSCOPES MARKET REVENUE, BY STATE, $M (2017-2030)
- FIG 19 SMITH & NEPHEW INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 20 THE COOPER COMPANIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 21 INTUITIVE SURGICAL INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 22 FUJIFILM HOLDINGS CORPORATION - REVENUE SPLIT BY SEGMENT (2023)
- FIG 23 CONMED CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 24 OLYMPUS CORPORATION OF THE AMERICAS - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 25 AMBU A/S - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 26 BOSTON SCIENTIFIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 27 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 28 STRYKER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 29 STERIS - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)
- FIG 30 B. BRAUN SE - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2023)
